207 related articles for article (PubMed ID: 36039384)
1. Immunomodulatory Effects of
Choi YJ; Shin SH; Shin HS
J Microbiol Biotechnol; 2022 Sep; 32(9):1186-1194. PubMed ID: 36039384
[TBL] [Abstract][Full Text] [Related]
2. The Combined Effect of Potential Probiotic Bacillus licheniformis MCC 2514 and Bifidobacterium breve NCIM 5671 Towards Anti-inflammatory Activity on HT-29 Cell Lines.
H S R; Halami PM
Probiotics Antimicrob Proteins; 2023 Apr; 15(2):351-362. PubMed ID: 34581975
[TBL] [Abstract][Full Text] [Related]
3. Bifidobacterium longum R0175 Protects Rats against d-Galactosamine-Induced Acute Liver Failure.
Wang K; Lv L; Yan R; Wang Q; Jiang H; Wu W; Li Y; Ye J; Wu J; Yang L; Bian X; Jiang X; Lu Y; Xie J; Wang Q; Shen J; Li L
mSphere; 2020 Jan; 5(1):. PubMed ID: 31996423
[TBL] [Abstract][Full Text] [Related]
4. Preventive oral supplementation with
Ribeiro WR; Queiroz AG; Mendes E; Casaro MB; Nascimento CM; Coelho LSSF; Martins FS; Leite-Silva VR; Ferreira CM
Benef Microbes; 2021 Apr; 12(2):199-209. PubMed ID: 33573507
[TBL] [Abstract][Full Text] [Related]
5. Differential immunomodulatory properties of Bifidobacterium logum strains: relevance to probiotic selection and clinical applications.
Medina M; Izquierdo E; Ennahar S; Sanz Y
Clin Exp Immunol; 2007 Dec; 150(3):531-8. PubMed ID: 17956582
[TBL] [Abstract][Full Text] [Related]
6. Effects of Taro (Colocasia esculenta) Water-Soluble Non-Starch Polysaccharide, Lactobacillus acidophilus, Bifidobacterium breve, Bifidobacterium infantis, and Their Synbiotic Mixtures on Pro-Inflammatory Cytokine Interleukin-8 Production.
Anwar M; Mros S; McConnell M; Bekhit AEA
Nutrients; 2022 May; 14(10):. PubMed ID: 35631269
[TBL] [Abstract][Full Text] [Related]
7. Administration of Bifidobacterium breve Decreases the Production of TNF-α in Children with Celiac Disease.
Klemenak M; Dolinšek J; Langerholc T; Di Gioia D; Mičetić-Turk D
Dig Dis Sci; 2015 Nov; 60(11):3386-92. PubMed ID: 26134988
[TBL] [Abstract][Full Text] [Related]
8. What happens to Bifidobacterium adolescentis and Bifidobacterium longum ssp. longum in an experimental environment with eukaryotic cells?
Jakubczyk D; Leszczyńska K; Pacyga-Prus K; Kozakiewicz D; Kazana-Płuszka W; Gełej D; Migdał P; Kruszakin R; Zabłocka A; Górska S
BMC Microbiol; 2024 Feb; 24(1):60. PubMed ID: 38373929
[TBL] [Abstract][Full Text] [Related]
9. Effects of
Sato S; Arai S; Kato K; Yoshida K; Iwabuchi N; Sagami T; Tanaka M
Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542727
[TBL] [Abstract][Full Text] [Related]
10. Cell-free culture supernatant of Bifidobacterium breve CNCM I-4035 decreases pro-inflammatory cytokines in human dendritic cells challenged with Salmonella typhi through TLR activation.
Bermudez-Brito M; Muñoz-Quezada S; Gomez-Llorente C; Matencio E; Bernal MJ; Romero F; Gil A
PLoS One; 2013; 8(3):e59370. PubMed ID: 23555025
[TBL] [Abstract][Full Text] [Related]
11.
Wang Q; Guo M; Liu Y; Xu M; Shi L; Li X; Zhao J; Zhang H; Wang G; Chen W
Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334879
[TBL] [Abstract][Full Text] [Related]
12. A randomized double-blind placebo-controlled trial of probiotics in post-surgical colorectal cancer.
Zaharuddin L; Mokhtar NM; Muhammad Nawawi KN; Raja Ali RA
BMC Gastroenterol; 2019 Jul; 19(1):131. PubMed ID: 31340751
[TBL] [Abstract][Full Text] [Related]
13. Lactic acid bacteria and bifidobacteria attenuate the proinflammatory response in intestinal epithelial cells induced by Salmonella enterica serovar Typhimurium.
Carey CM; Kostrzynska M
Can J Microbiol; 2013 Jan; 59(1):9-17. PubMed ID: 23391223
[TBL] [Abstract][Full Text] [Related]
14. Digestion of Intact Gluten Proteins by
de Almeida NEC; Esteves FG; Dos Santos-Pinto JRA; Peres de Paula C; da Cunha AF; Malavazi I; Palma MS; Rodrigues-Filho E
J Agric Food Chem; 2020 Apr; 68(15):4485-4492. PubMed ID: 32195585
[TBL] [Abstract][Full Text] [Related]
15.
Niu MM; Guo HX; Cai JW; Meng XC
Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145047
[TBL] [Abstract][Full Text] [Related]
16. Selenium-enriched Bifidobacterium longum DD98 attenuates irinotecan-induced intestinal and hepatic toxicity in vitro and in vivo.
Zhu H; Lu C; Gao F; Qian Z; Yin Y; Kan S; Chen D
Biomed Pharmacother; 2021 Nov; 143():112192. PubMed ID: 34649340
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells.
Imaoka A; Shima T; Kato K; Mizuno S; Uehara T; Matsumoto S; Setoyama H; Hara T; Umesaki Y
World J Gastroenterol; 2008 Apr; 14(16):2511-6. PubMed ID: 18442197
[TBL] [Abstract][Full Text] [Related]
18. Immunostimulatory effect of faecal Bifidobacterium species of breast-fed and formula-fed infants in a peripheral blood mononuclear cell/Caco-2 co-culture system.
Pozo-Rubio T; Mujico JR; Marcos A; Puertollano E; Nadal I; Sanz Y; Nova E
Br J Nutr; 2011 Oct; 106(8):1216-23. PubMed ID: 21736809
[TBL] [Abstract][Full Text] [Related]
19. Immunoregulatory effect of bifidobacteria strains in porcine intestinal epithelial cells through modulation of ubiquitin-editing enzyme A20 expression.
Tomosada Y; Villena J; Murata K; Chiba E; Shimazu T; Aso H; Iwabuchi N; Xiao JZ; Saito T; Kitazawa H
PLoS One; 2013; 8(3):e59259. PubMed ID: 23555642
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Bifidobacterium breve NCC2950 against DSS-induced colitis is dependent on bacterial preparation and timing of administration.
Hayes CL; Natividad JM; Jury J; Martin R; Langella P; Verdu EF
Benef Microbes; 2014 Mar; 5(1):79-88. PubMed ID: 24533977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
